Reasoned opinion on the modification of the existing MRL for cyproconazole in poppy seed

In accordance with Article 6 of Regulation (EC) No 396/2005, the Czech Republic, herewith referred to as the evaluating Member State (EMS), received an application from Syngenta Czech s.r.o to modify the existing MRL for the active substance cyproconazole in poppy seed. In order to accommodate for the intended use of cyproconazole, the EMS proposed to raise the existing MRL from the limit of quantification (0.05* mg/kg) to 0.3 mg/kg. The EMS drafted an evaluation report according to Article 8 of Regulation (EC) No 396/2005, which was submitted to the European Commission and forwarded to EFSA. According to EFSA the data are sufficient to derive a MRL proposal of 0.4 mg/kg for the proposed use on poppy seed. There is evidence that adequate analytical enforcement methods are available to control residues of cyproconazole in plant matrices with high fat content at the LOQ of 0.01 mg/kg. Based on the risk assessment results, EFSA concludes that intended use of cyproconazole on poppy seed will not result in a consumer exposure exceeding the toxicological reference values for the parent compound and therefore is unlikely to pose a public health concern.